Total Payments
$560,607
2024 Payments
$154,437
Companies
9
Transactions
361
Medicare Patients
4,190
Medicare Billing
$353,300
Payment Breakdown by Category
Other$315,346 (56.3%)
Consulting$200,002 (35.7%)
Travel$30,031 (5.4%)
Food & Beverage$7,734 (1.4%)
Research$7,494 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $310,166 | 114 | 55.3% |
| Consulting Fee | $200,002 | 54 | 35.7% |
| Travel and Lodging | $30,031 | 81 | 5.4% |
| Food and Beverage | $7,734 | 97 | 1.4% |
| Unspecified | $7,494 | 14 | 1.3% |
| Compensation for serving as faculty or as a speaker for a medical education program | $5,180 | 1 | 0.9% |
Payments by Type
General
$553,113
347 transactions
Research
$7,494
14 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PROGENICS PHARMACEUTICALS, INC. | $351,633 | 247 | $0 (2024) |
| GE HEALTHCARE | $97,626 | 68 | $0 (2024) |
| Blue Earth Diagnostics Limited | $79,643 | 13 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $22,079 | 22 | $0 (2019) |
| Siemens Medical Solutions USA, Inc. | $5,108 | 3 | $0 (2022) |
| GENZYME CORPORATION | $2,140 | 3 | $0 (2020) |
| Puma Biotechnology, Inc. | $2,085 | 2 | $0 (2019) |
| Celgene Corporation | $153.49 | 1 | $0 (2018) |
| Telix Pharmaceuticals | $138.73 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $154,437 | 131 | PROGENICS PHARMACEUTICALS, INC. ($105,006) |
| 2023 | $161,086 | 106 | Progenics Pharmaceuticals, Inc. ($152,447) |
| 2022 | $122,062 | 79 | Progenics Pharmaceuticals, Inc. ($94,180) |
| 2021 | $91,489 | 11 | Blue Earth Diagnostics Limited ($76,380) |
| 2020 | $7,040 | 5 | Siemens Medical Solutions USA, Inc. ($4,900) |
| 2019 | $14,129 | 18 | SANOFI-AVENTIS U.S. LLC ($12,044) |
| 2018 | $10,281 | 9 | SANOFI-AVENTIS U.S. LLC ($10,035) |
| 2017 | $82.85 | 2 | Blue Earth Diagnostics Limited ($82.85) |
All Payment Transactions
361 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 11/27/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $8.29 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 11/20/2024 | GE HEALTHCARE | Cerianna (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,544.00 | General |
| Category: Pharma Imaging Agents - Nuclear Imaging | ||||||
| 11/20/2024 | GE HEALTHCARE | Cerianna (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,848.00 | General |
| Category: Pharma Imaging Agents - Nuclear Imaging | ||||||
| 11/06/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 10/07/2024 | GE HEALTHCARE | Cerianna (Drug) | Travel and Lodging | In-kind items and services | $1,323.00 | General |
| Category: Pharma Imaging Agents - Nuclear Imaging | ||||||
| 10/07/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $127.50 | General |
| 09/12/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Consulting Fee | Cash or cash equivalent | $7,500.00 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/02/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,680.00 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/02/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Travel and Lodging | In-kind items and services | $396.68 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/02/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Travel and Lodging | In-kind items and services | $209.02 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/02/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $34.55 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/02/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/01/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,560.00 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/01/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Travel and Lodging | In-kind items and services | $245.18 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/01/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/03/2024 | GE HEALTHCARE | Cerianna (Drug) | Consulting Fee | Cash or cash equivalent | $3,080.00 | General |
| Category: Pharma Imaging Agents - Nuclear Imaging | ||||||
| 07/03/2024 | GE HEALTHCARE | Cerianna (Drug) | Consulting Fee | Cash or cash equivalent | $616.00 | General |
| Category: Pharma Imaging Agents - Nuclear Imaging | ||||||
| 07/03/2024 | GE HEALTHCARE | Cerianna (Drug) | Consulting Fee | Cash or cash equivalent | $616.00 | General |
| Category: Pharma Imaging Agents - Nuclear Imaging | ||||||
| 07/03/2024 | GE HEALTHCARE | Cerianna (Drug) | Consulting Fee | Cash or cash equivalent | $616.00 | General |
| Category: Pharma Imaging Agents - Nuclear Imaging | ||||||
| 07/03/2024 | GE HEALTHCARE | Cerianna (Drug) | Consulting Fee | Cash or cash equivalent | $616.00 | General |
| Category: Pharma Imaging Agents - Nuclear Imaging | ||||||
| 07/03/2024 | GE HEALTHCARE | Cerianna (Drug) | Consulting Fee | Cash or cash equivalent | $616.00 | General |
| Category: Pharma Imaging Agents - Nuclear Imaging | ||||||
| 07/03/2024 | GE HEALTHCARE | Cerianna (Drug) | Consulting Fee | Cash or cash equivalent | $308.00 | General |
| Category: Pharma Imaging Agents - Nuclear Imaging | ||||||
| 07/03/2024 | GE HEALTHCARE | Cerianna (Drug) | Consulting Fee | Cash or cash equivalent | $308.00 | General |
| Category: Pharma Imaging Agents - Nuclear Imaging | ||||||
| 06/20/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,960.00 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 1/2 study for the safety, efficacy, pharmacokinetic and pharmacodynamics evaluation of SAR439859, administered orally as monotherapy, then in combination with palbociclib in postmenopausal wom | SANOFI-AVENTIS U.S. LLC | $4,502 | 9 |
| A Phase 1-2 Study for the Safety, Efficacy, Pharmacokinetic and Pharmacodynamics Evaluation of SAR439859, Administered Orally as Monotherapy, Then in Combination With Palbociclib in Postmenopausal Women With Estrogen Receptor-positive Advanced Breast Canc | GENZYME CORPORATION | $1,247 | 2 |
| A Phase 1-2 Study for the Safety, Efficacy, Pharmacokinetic and Pharmacodynamics Evaluation of SAR439859, Administered Orally as Monotherapy, Then in Combination With Palbociclib in Postmenopausal Wom | GENZYME CORPORATION | $893.33 | 1 |
| Phase 1/2 dose-escalation and expansion study investigating SAR439859 +/- palbociclib in postmenopausal women with estrogen receptor-positive (ER+)/HER2- metastatic breast cancer | SANOFI-AVENTIS U.S. LLC | $454.29 | 1 |
| Dose-escalation study of SAR439859, an oral selective estrogen receptor (ER) degrader (SERD), in postmenopausal women with ER+/HER2- metastatic breast cancer (mBC) | SANOFI-AVENTIS U.S. LLC | $397.50 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 588 | 638 | $230,732 | $50,416 |
| 2022 | 16 | 1,341 | 1,444 | $519,217 | $112,865 |
| 2021 | 18 | 1,600 | 1,720 | $594,245 | $129,258 |
| 2020 | 7 | 661 | 668 | $316,419 | $60,761 |
Total Patients
4,190
Total Services
4,470
Medicare Billing
$353,300
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Facility | 2023 | 274 | 287 | $114,226 | $27,239 | 23.8% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Facility | 2023 | 54 | 57 | $21,318 | $4,224 | 19.8% |
| 78816 | Nuclear medicine study whole body with ct scan | Facility | 2023 | 38 | 40 | $22,400 | $3,881 | 17.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 41 | 41 | $14,309 | $2,604 | 18.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 16 | 16 | $9,136 | $2,483 | 27.2% |
| 79101 | Radioactive drug therapy through a vein | Facility | 2023 | 15 | 27 | $10,452 | $2,176 | 20.8% |
| 71260 | Ct scan of chest with contrast | Facility | 2023 | 42 | 45 | $12,420 | $2,031 | 16.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 21 | 35 | $7,140 | $1,982 | 27.8% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Facility | 2023 | 17 | 18 | $6,276 | $1,277 | 20.3% |
| 78306 | Nuclear medicine study of bone and/or joint whole body | Facility | 2023 | 31 | 32 | $6,044 | $1,077 | 17.8% |
| 71250 | Ct scan of chest without contrast | Facility | 2023 | 16 | 17 | $4,124 | $743.29 | 18.0% |
| 78226 | Nuclear medicine study of liver and bile duct system | Facility | 2023 | 12 | 12 | $984.00 | $354.36 | 36.0% |
| 78264 | Nuclear medicine study of stomach to assess emptying | Facility | 2023 | 11 | 11 | $1,903 | $347.38 | 18.3% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Facility | 2022 | 588 | 656 | $261,088 | $63,248 | 24.2% |
| 78816 | Nuclear medicine study whole body with ct scan | Facility | 2022 | 97 | 112 | $62,720 | $10,912 | 17.4% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Facility | 2022 | 130 | 137 | $51,238 | $10,117 | 19.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 95 | 95 | $33,155 | $5,979 | 18.0% |
| 71260 | Ct scan of chest with contrast | Facility | 2022 | 96 | 102 | $28,152 | $4,700 | 16.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 22 | 22 | $12,562 | $3,481 | 27.7% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Facility | 2022 | 47 | 49 | $17,542 | $3,412 | 19.4% |
| 78306 | Nuclear medicine study of bone and/or joint whole body | Facility | 2022 | 83 | 86 | $16,512 | $3,016 | 18.3% |
| 71250 | Ct scan of chest without contrast | Facility | 2022 | 35 | 37 | $9,546 | $1,655 | 17.3% |
| 78803 | Nuclear medicine study, 1 area with spect | Facility | 2022 | 34 | 34 | $8,296 | $1,484 | 17.9% |
| 78072 | Nuclear medicine study of parathyroid with spect and ct scan | Facility | 2022 | 18 | 18 | $4,698 | $1,153 | 24.5% |
| 78582 | Nuclear medicine study of lung ventilation and circulation | Facility | 2022 | 24 | 24 | $2,808 | $1,050 | 37.4% |
About Gary Ulaner, M.D. PH.D
Gary Ulaner, M.D. PH.D is a Diagnostic Radiology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1073730727.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Gary Ulaner, M.D. PH.D has received a total of $560,607 in payments from pharmaceutical and medical device companies, with $154,437 received in 2024. These payments were reported across 361 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($310,166).
As a Medicare-enrolled provider, Ulaner has provided services to 4,190 Medicare beneficiaries, totaling 4,470 services with total Medicare billing of $353,300. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Diagnostic Radiology
- Location Los Angeles, CA
- Active Since 04/20/2007
- Last Updated 05/08/2009
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1073730727
Products in Payments
- PYLARIFY (Drug) $349,383
- Cerianna (Drug) $54,415
- SAR439859 (Drug) $19,156
- F-18 FDG (Device) $4,900
- POSLUMA (Drug) $2,950
- SAR439459 (Drug) $2,923
- Nerlynx (Drug) $2,085
- Axumin (Drug) $312.76
- NAEOTOM Alpha (Device) $208.19
- Revlimid (Drug) $153.49
- ILLUCCIX (Drug) $138.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Los Angeles
Edward Lee, Md, MD
Diagnostic Radiology — Payments: $1.3M
Diagnostic Radiology $1.3M
Dr. John Moriarty, M.d. Mrcpi Ffr(Rcsi), M.D. MRCPI FFR(RCSI)
Diagnostic Radiology — Payments: $866,087
Diagnostic Radiology $866,087
Mary Yamashita, Md, MD
Diagnostic Radiology — Payments: $359,279
Diagnostic Radiology $359,279
Dr. Arthur Baghdanian, Md, MD
Diagnostic Radiology — Payments: $270,314
Diagnostic Radiology $270,314
Jonathan Goldin, Md, MD
Diagnostic Radiology — Payments: $254,449
Diagnostic Radiology $254,449
Dr. Steven Raman, Md, MD
Diagnostic Radiology — Payments: $243,774
Diagnostic Radiology $243,774